The manufacture of gene therapy vectors is shifting to more modern technologies.

Bioprocessing for Gene Therapy Viral Vectors

The set-up and optimization of a loss-in-weight feeder is demonstrated. 

Loss-in-Weight Feeding of Poorly Flowing Materials

Topic

Articles

Wacker will support production of CureVac’s COVID-19 mRNA-based vaccine candidate at its biotech site in Amsterdam, with production scheduled to start in the first half of 2021.

CureVac and Wacker Sign Manufacturing Contract for COVID-19 Vaccine Candidate

A new facility near Frankfurt, Germany expands Avantor's geographic reach and supports the growing demand for scientific research and clinical trial sample storage.

Avantor Opens Biorepository Facility in Germany 

The new super plant, being built in Incheon, South Korea, will have a total biopharmaceutical manufacturing capacity of 256,000 L.

Samsung Biologics Begins Construction on Fourth Biopharma Manufacturing Plant 

The companies have formed a long-term manufacturing agreement to accelerate the global supply for Lilly’s COVID-19 antibody therapeutics.

Samsung Biologics and Lilly Partner to Accelerate Delivery of COVID-19 Antibody Therapeutics

The agreement follows a recent announcement that Sartorius plans to invest $100 million in Songdo, South Korea’s bio cluster.

Samsung Biologics Signs MOU with Sartorius to Enhance Supply Chain for Biomedicines

The agreement will allow Roche to use CEVEC’s proprietary ELEVECTA technology, which is designed to enable fully scalable, high-performance AAV vector production in suspension bioprocesses.

Roche in Agreement to Use CEVEC’s ELEVECTA Technology for AAV Manufacture

ApiJect to Build US Facilities for Needle Hubs and Prefilled Syringes

Watson-Marlow Limited Ireland has revealed plans for a new ISO 14644-1 Class 7 cleanroom to be added to the company’s existing site in Cork, Ireland.

Watson-Marlow Reveals Plans for New Facility in Cork, Ireland

CordenPharma has announced the expansion of its non-GMP SPPS manufacturing capacity at its Centre of Excellence for Peptide Process Development and non-GMP manufacturing in Frankfurt, Germany.

CordenPharma Expands Non-GMP Solid-Phase Peptide Synthesis Manufacturing Capacity

Bone Therapeutics has reported the completion of Catalent’s acquisition of Skeletal Cell Therapy Support SA (SCTS)—Bone Therapeutics’ cell therapy manufacturing subsidiary.

Catalent Completes Acquisition of Bone Therapeutics’ Cell Therapy Manufacturing Subsidiary

Aseptic/Sterile Processing

Cleanroom Equipment and Supplies

Clinical Trial Materials

Equipment

Facility Design and Engineering

Fill-Finish

Information Technology

Manufacturing Equipment, Biologics

Manufacturing Equipment, Downstream Processing

Manufacturing Equipment, Fill-Finish

Manufacturing Equipment, Solid Dose Drugs

Manufacturing Equipment, Upstream Processing

Manufacturing Services

Manufacturing Systems, Single-Use

Manufacturing, Biologic Drugs

Manufacturing, Biosimilars and Biobetters

Manufacturing, Cell Culture and Fermentation

Manufacturing, Cell Therapies

Manufacturing, Cell-Line Selection

Manufacturing, Combination Drugs

Manufacturing, Continuous Solid Dosage Processing

Manufacturing, Drug Products

Manufacturing, Expression Systems

Manufacturing, Gene Therapies

Manufacturing, Inhalation Drugs

Manufacturing, Liquid Drug Products

Manufacturing, Lyophilization

Manufacturing, Nucleic Acids

Manufacturing, Parenterals and Injectables

Manufacturing, Process Chromatography

Manufacturing, Recombinant Proteins

Manufacturing, Separation and Purification

Manufacturing, Solid Dosage Drugs

Manufacturing, Specialty Dosage Forms

Manufacturing, Topical Drugs

Manufacturing, Vaccines

Packaging Trends

Packaging, Labeling, and Distribution Systems

PharmTech Products

Process Control, Automation, and PAT

Supply Chain

Technology Transfer

Viral Clearance

Manufacturing